OTCMKTS:IGXT IntelGenx Technologies (IGXT) Stock Price, News & Analysis → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free IGXT Stock Alerts $0.18 +0.01 (+5.88%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.16▼$0.1850-Day Range$0.14▼$0.1852-Week Range$0.09▼$0.26Volume50,727 shsAverage Volume91,317 shsMarket Capitalization$31.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get IntelGenx Technologies alerts: Email Address Ad Behind the MarketsThe AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.Here's how you can invest >>> About IntelGenx Technologies Stock (OTCMKTS:IGXT)IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine; INT0046/2018 and INT0055/2021 are for adult use; INT0007/2006, an oral film product for treatment of erectile dysfunction; INT0043/2015, an oral film containing montelukast for treatment of Alzheimer; INT0027/2011 to treat opioid addition; INT0010/2006 for treatment of neuropathic pain and nausea in cancer patients undergoing chemotherapy; INT0036/2013, an oral film product for schizophrenia or bipolar 1 disorder; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0053/2020, and INT0054/2020. The company has licensing, development, and supply agreement with Tilray, Inc.; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was incorporated in 1999 and is headquartered in Montreal, Canada.Read More IGXT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IGXT Stock News HeadlinesMarch 23, 2024 | seekingalpha.comIntelGenx Technologies Corp. (IGXT) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | insidermonkey.comIntelGenx Technologies Corp. (PNK:IGXT) Q4 2023 Earnings Call TranscriptMarch 28, 2024 | Behind the Markets (Ad)4x Better than Bitcoin4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 21, 2024 | investorplace.comIGXT Stock Earnings: Intelgenx Technologies Reported Results for Q4 2023March 21, 2024 | globenewswire.comIntelGenx Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 16, 2024 | seekingalpha.comIGXT IntelGenx Technologies Corp.March 14, 2024 | globenewswire.comIntelGenx to Report Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 – Conference Call to FollowMarch 11, 2024 | globenewswire.comIntelGenx Enters Into a Third Amended and Restated Loan Agreement With atai Life SciencesMarch 28, 2024 | Huge Alerts (Ad)Trending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! February 20, 2024 | finance.yahoo.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comUPDATE -- IntelGenx Launches Preferred Share Regulation A OfferingFebruary 20, 2024 | globenewswire.comIntelGenx Launches Preferred Share Regulation A OfferingFebruary 19, 2024 | finance.yahoo.comIntelGenx Technologies Corp. (IGXT)February 5, 2024 | finance.yahoo.comStudies Validate Advantages of Administering Drugs to Pets via IntelGenx’s VetaFilm® PlatformDecember 7, 2023 | morningstar.comIntelgenx Technologies Corp IGXTNovember 14, 2023 | finance.yahoo.comIntelGenx Receives Approval to Conduct ’MONTPARK’ Montelukast VersaFilm® Phase 2 Clinical Trial in Patients with Parkinson's DiseaseNovember 13, 2023 | finance.yahoo.comIntelGenx Reminds Shareholders to Vote at Upcoming Special MeetingNovember 10, 2023 | insidermonkey.comIntelGenx Technologies Corp. (PNK:IGXT) Q3 2023 Earnings Call TranscriptNovember 9, 2023 | finance.yahoo.comIntelGenx Reports Third Quarter 2023 Financial ResultsNovember 6, 2023 | finance.yahoo.comIntelGenx Announces Co-development and Commercialization of Cannabinoid-Infused VersaFilm® Products with TilraySeptember 21, 2023 | finance.yahoo.comIntelGenx Provides RIZAFILM® U.S. Commercialization UpdateAugust 31, 2023 | finance.yahoo.comIntelGenx Announces Closing of First Tranche of Non-Brokered Private Placement From Strategic Partner for Approximate Aggregate Gross Proceeds of US$3 Million (Including US$750,000 to be Received by the Company Once Shareholder Approvals Have Been Obtained)August 16, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Reports Second Quarter 2023 Financial ResultsAugust 15, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (PNK:IGXT) Q2 2023 Earnings Call TranscriptAugust 15, 2023 | finance.yahoo.comIntelGenx Technologies Corp. (IGXT) Q2 2023 Earnings Call TranscriptAugust 14, 2023 | finance.yahoo.comIntelGenx Reports Second Quarter 2023 Financial ResultsAugust 10, 2023 | finance.yahoo.comIntelGenx Announces First Agreement for CDMO Packaging ServicesSee More Headlines Receive IGXT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/21/2024Today3/27/2024Next Earnings (Estimated)3/27/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:IGXT CUSIP45822R101 CIK1098880 Webwww.intelgenx.com Phone(514) 331-7440Fax514-331-0436Employees4Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,930,000.00 Net Margins-955.44% Pretax Margin-955.44% Return on EquityN/A Return on Assets-128.18% Debt Debt-to-Equity RatioN/A Current Ratio0.41 Quick Ratio0.40 Sales & Book Value Annual Sales$1.04 million Price / Sales30.23 Cash FlowN/A Price / Cash FlowN/A Book Value($0.07) per share Price / Book-2.57Miscellaneous Outstanding Shares174,660,000Free Float101,214,000Market Cap$31.44 million OptionableNot Optionable Beta2.42 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. André Godin C.A. (Age 60)CPA, CA, CPA, President & CFO Comp: $242.07kMr. Tommy Kenny J.D. (Age 37)L.L.B., M.Sc., Senior VP & General Counsel Comp: $141.21kMs. Nadine Paiement (Age 47)Vice-Chair of Scientific Advisory Board and VP of Research & Development - IntelGenx Corp Comp: $151.69kMr. Dwight GorhamChief Executive OfficerStephen KilmerInvestor Relations OfficerMs. Ingrid Zerbe (Age 70)Corporate Secretary Zenoz Nina PourhassanVP of Quality Operations of SubsidiaryMore ExecutivesKey CompetitorsHelix BioPharmaOTCMKTS:HBPCFAlaunos TherapeuticsNASDAQ:TCRTSpruce BiosciencesNASDAQ:SPRBAptorum GroupNASDAQ:APMFSD PharmaNASDAQ:HUGEView All Competitors IGXT Stock Analysis - Frequently Asked Questions How have IGXT shares performed in 2024? IntelGenx Technologies' stock was trading at $0.1381 at the start of the year. Since then, IGXT stock has increased by 30.3% and is now trading at $0.18. View the best growth stocks for 2024 here. Are investors shorting IntelGenx Technologies? IntelGenx Technologies saw a decrease in short interest during the month of March. As of March 15th, there was short interest totaling 600 shares, a decrease of 60.0% from the February 29th total of 1,500 shares. Based on an average trading volume of 179,100 shares, the short-interest ratio is presently 0.0 days. View IntelGenx Technologies' Short Interest. How were IntelGenx Technologies' earnings last quarter? IntelGenx Technologies Corp. (OTCMKTS:IGXT) announced its quarterly earnings data on Thursday, March, 21st. The company reported ($0.02) EPS for the quarter. The firm had revenue of $0.43 million for the quarter. What other stocks do shareholders of IntelGenx Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include Cronos Group (CRON), Zevra Therapeutics (KMPH), Exelixis (EXEL), SemiLEDs (LEDS), New Residential Investment (NRZ), Anavex Life Sciences (AVXL), BioDelivery Sciences International (BDSI), BIOLASE (BIOL) and Ocugen (OCGN). How do I buy shares of IntelGenx Technologies? Shares of IGXT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IGXT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.